Answers are grounded in this paper and cite their sources.
Molecular-dynamics (MD) simulations are usually run for a prespecified duration, even when the goal is to estimate an equilibrium observable to a stated precision. Stopping as soon as an estimated uncertainty becomes small enough is attractive, but repeated inspection invalidates uncertainty statements calibrated for a fixed time. We formulate data-dependent stopping as an inferential problem with an explicit precision target and a simultaneous-in-time coverage requirement, and organise it into four gated stages: temporal prediction against strong baselines, uncertainty calibration, an anytime-valid stopping rule, and measured high-performancecomputing (HPC) savings. We report exploratory first-stage results on four incrementally assembled ATLAS cohorts, using sequence-grouped cross-validation and a target computed only from frames after a 20 ns prefix. In the largest cohort (757 systems, 1,243 replicas, 689 sequence groups), ridge regression on 48 prefix summaries and a residual gated recurrent unit (GRU) both reduced RMSD mean absolute error relative to last-value persistence (0.610 and 0.636 versus 0.673 Å; paired bootstrap intervals excluding zero), whereas the GRU–ridge difference was not significant in any cohort. A genuine structure-only baseline, a compatible mdCATH analysis, sequential coverage and HPC cost measurements are still outstanding, so no stopping policy or computational saving is claimed.
No takes yet. Share an insight, caveat, or question.
Hernando-Gallego et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: